There’s nothing more sacred than the physician-patient relationship, and we
physicians have the responsibility to make sure nothing gets in the way of that
relationship–or even appears to get in the way.” …
the industry looks fairly safe, despite the U.S. financial crisis, but others
say that because of the potential tax hit, U.S. drug companies are more likely
to go into debt than to repatriate cash. …
According to a new Datamonitor report, cash-rich drugmakers are poised to take
advantage of the credit crunch, in part because they didn’t
overdose on the cheap debt that has trapped so many companies now that credit
has dried up. …
This $62 million settlement is dwarfed in comparison with previous Zyprexa
deals, including a $1 billion resolution of several thousand patient-safety
claims. …